Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × tucatinib × Breast × Clear all

Phase

Status

Recruiting 13 Completed 8 Active not recruiting 7 Withdrawn 4 Terminated 3 Not yet recruiting 1 No longer available 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1 Breast 1

Conditions

HER2-positive Breast Cancer 1

Interventions

Trastuzumab 23 Carboplatin 20 Capecitabine 19 Cyclophosphamide 17 pertuzumab 16 Paclitaxel 16 pyrotinib 15 Docetaxel 15 Letrozole 12 Fulvestrant 11 trastuzumab deruxtecan 10 Radiotherapy 10 palbociclib 9 dalpiciclib 9 Epirubicin 9 sacituzumab govitecan 8 pembrolizumab 8 abemaciclib 8 Drug Therapy 8 Doxorubicin 8 eribulin 7 Vinorelbine 7 Standard of Care 7 Specimen Handling 7 Anastrozole 7 130-nm albumin-bound paclitaxel 7 Tamoxifen 6 toripalimab 5 exemestane 5 Neoadjuvant Therapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07413939 2026-03-10

BREnnA

Hoffmann-La Roche

Phase 2/3 Not yet recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡